Biochemistry Analyzers in New Hampshire

Immundiagnostik, Inc. is the North American subsidiary of Immundiagnostik AG, a clinical laboratory diagnostics company specializing in immunoassay-based detection solutions. The company develops and distributes ELISA kits and automated chemiluminescent analyzers for research and clinical laboratory applications across multiple therapeutic areas including cardiovascular and renal disease, bone and mineral metabolism, immunology, and complementary health. Their flagship product is the ECL100 Chemiluminescent Immunoassay Analyzer, a high-throughput automated platform for laboratory testing. The product portfolio includes specialized ELISA kits such as ox-LDL (oxidized low-density lipoprotein), 1,25-(OH)2 Vitamin D, EDN (endothelin), and HERO (Histamine Elimination Ratio) assays. Immundiagnostik serves clinical laboratories, research institutions, and healthcare facilities requiring sensitive and reliable biomarker detection. The company provides comprehensive support services including expert-guided assay validation assistance, custom bulk packaging solutions, technical support, and on-site training. They participate in major medical conferences (e.g., DDW 2026) and maintain a regional sales structure across North America with dedicated sales directors. The company is positioned as a supplier of both detection instrumentation and consumable assay kits for specialized laboratory diagnostics.

ALPCO (American Laboratory Products Company, Ltd.) is a global in vitro diagnostics (IVD) and research-use-only (RUO) company headquartered in Salem, New Hampshire. Founded in 1991 as an immunoassay importer and distributor, ALPCO has evolved into a leading producer of immunodiagnostic reagents and molecular diagnostics solutions. Following its April 2022 merger with GeneProof, the company enhanced its capabilities in PCR technologies for infectious disease and genetic mutation detection. ALPCO specializes in high-sensitivity immunodiagnostic assays, real-time PCR kits, and multiplex allergy assays with applications across gastroenterology, autoimmune conditions, metabolic disorders, and infectious diseases. The company offers automated sample-to-answer platforms and chemiluminescence-based immunoassays (ELISA, immunoturbidimetric), emphasizing workflow efficiency and supporting clinical laboratories and research facilities globally.

BUHLMANN Diagnostics Corp is a clinical laboratory diagnostic company specializing in immunoassay and biochemical testing solutions. The company manufactures and distributes FDA-cleared in vitro diagnostic (IVD) assays across multiple therapeutic and diagnostic areas including gastroenterology, autoimmunity, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. Core product lines include calprotectin assays (BÜHLMANN fCAL® turbo and ELISA), pancreatic elastase (BÜHLMANN fPELA® turbo), Quantum Blue® point-of-care and laboratory immunoassay systems, Flow CAST® and CAST® ELISA for allergy testing, and neuroimmunology assays for peripheral neuropathy detection (GanglioCombi® MAG and anti-ganglioside antibody tests). The company offers random-access turbidimetric immunoassays, ELISA-based methods, and extraction technologies (CALEX® Cap) for improved analytical stability and laboratory workflow automation. FDA clearance is documented for multiple products including fCAL® turbo, fCAL® ELISA, fPELA® turbo, ACE KINETIC, and CIC-C1q ELISA. BUHLMANN serves clinical laboratories, hospital pathology departments, gastroenterology centers, and specialty diagnostic facilities. The organization maintains quality management systems and actively participates in medical and scientific conferences (e.g., DDW 2026). Support includes technical customer service, FAQs, and product-specific literature.